Plus Therapeutics Inc. (PSTV)
NASDAQ: PSTV
· Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM
0.57
-9.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
Plus Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 9.87M | 76K | 1.22M | 4.91M | 2.9M | 8.55M | 11.01M | 10.89M | 12.72M | 18.12M | 20.27M | 18.09M | 21.24M | 18.4M | 21.28M | 17.16M | 14.45M |
Short-Term Investments | n/a | 3.53M | 3.56M | 3.52M | 323K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 463K | 12K | 32K | 32K | 32K | 32K | 32K | 12K | 12K | 12K | 12K | 16K | 16K | 16K | 16K | 16K | 16K |
Receivables | n/a | 571K | n/a | n/a | n/a | n/a | 91K | 718K | n/a | n/a | 73K | n/a | n/a | 7K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 436K | 576K | 945K | 989K | n/a | 487K | 751K | 906K | n/a | 540K | 799K | 865K | n/a | 817K | 840K | 999K |
Total Current Assets | 10.42M | 5.26M | 5.36M | 9.38M | 4.21M | 9.83M | 11.58M | 12.36M | 13.63M | 21.82M | 20.88M | 18.89M | 22.1M | 19.72M | 22.1M | 18M | 15.45M |
Property-Plant & Equipment | 362K | 521K | 697K | 871K | 971K | 1.11M | 1.24M | 1.39M | 1.55M | 1.57M | 1.73M | 1.86M | 1.87M | 1.82M | 2.21M | 2.38M | 2.42M |
Goodwill & Intangibles | 807K | 841K | 885K | 929K | 405K | 414K | 421K | 436K | 451K | 466K | 485K | 503K | 522K | 423K | 432K | 441K | 449K |
Total Long-Term Assets | 1.63M | 1.37M | 1.61M | 1.83M | 1.41M | 1.55M | 1.69M | 1.83M | 2.01M | 2.05M | 2.23M | 2.38M | 2.41M | 2.26M | 2.65M | 2.83M | 2.89M |
Total Assets | 12.06M | 6.63M | 6.98M | 11.21M | 5.62M | 11.39M | 13.28M | 14.2M | 15.64M | 23.87M | 23.1M | 21.27M | 24.52M | 21.98M | 24.75M | 20.83M | 18.34M |
Account Payables | 9.22M | 9.47M | n/a | 6.95M | 6.45M | 4.76M | 6.07M | 6.58M | n/a | 8.36M | 5.71M | 5.26M | 3.2M | 2.61M | 2.63M | 1.61M | 1.71M |
Deferred Revenue | 1.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 141K | n/a | n/a | n/a |
Short-Term Debt | 40K | 3.34M | 3.36M | 3.29M | 3.59M | 3.98M | 4.35M | 4.71M | 5.06M | 1.72M | 1.72M | 1.71M | 1.72M | 1.72M | 6.75M | 6.62M | 6.49M |
Other Current Liabilities | n/a | 2.74M | 8.68M | 8.37M | 247K | 370K | n/a | n/a | 7.63M | 215K | -107K | -104K | -110K | 263K | n/a | n/a | 3K |
Total Current Liabilities | 10.56M | 15.55M | 12.11M | 18.79M | 10.4M | 10.73M | 10.54M | 11.4M | 12.8M | 11.85M | 7.42M | 6.97M | 4.92M | 5.87M | 9.49M | 8.35M | 8.31M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.79M | 4.11M | 4.42M | 4.72M | 5M | n/a | n/a | n/a |
Other Long-Term Liabilities | 25.14M | n/a | n/a | n/a | n/a | 1.92M | n/a | n/a | n/a | 1.64M | n/a | n/a | n/a | 1K | 3K | 5K | 5K |
Total Long-Term Liabilities | 25.14M | 31K | 40K | 50K | 59K | 2.01M | 118K | 136K | 166K | 5.57M | 4.28M | 4.62M | 4.95M | 5.28M | 507K | 535K | 508K |
Total Liabilities | 35.7M | 15.58M | 12.15M | 18.84M | 10.46M | 12.74M | 10.66M | 11.54M | 12.96M | 17.42M | 11.7M | 11.59M | 9.87M | 11.14M | 9.99M | 8.89M | 8.82M |
Total Debt | 40K | 3.37M | 3.4M | 3.43M | 3.76M | 4.18M | 4.58M | 4.96M | 5.33M | 5.64M | 6M | 6.33M | 6.67M | 6.99M | 7.36M | 7.28M | 7.1M |
Common Stock | 17K | 6K | 6K | 6K | 5K | 5K | 5K | 3K | 36K | 34K | 32K | 22K | 22K | 16K | 15K | 12K | 10K |
Retained Earnings | -510.88M | -493.48M | -489.58M | -486.7M | -483.76M | -480.5M | -476.69M | -473.47M | -471.99M | -467.19M | -461.53M | -456.31M | -451.03M | -446.91M | -442.75M | -439.03M | -436.23M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -23.64M | -8.95M | -5.17M | -7.63M | -4.84M | -1.35M | 2.62M | 2.66M | 2.68M | 6.45M | 11.4M | 9.68M | 14.64M | 10.84M | 14.76M | 11.95M | 9.51M |
Total Investments | n/a | 3.53M | 3.56M | 3.52M | 323K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |